Evidence map›Paper›PMID 42534908›Full record

ArticleFrontiers in immunology2026

High-resolution mapping of chromatin conformation in HBeAg-treated macrophage provides insights into pathogenesis of HBV-related liver diseases.

Tiantian Liu, Xiaoyu Xie, Shujun Ma, Huiling Cao, Wenwen Wang, Zhen Yu, Yuemin Feng, Jianni Qi, Hongjun Bian

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tiantian Liu *Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Xiaoyu Xie *Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Shujun Ma *Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Huiling CaoShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Wenwen WangShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Zhen YuShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Yuemin FengShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Jianni QiShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
Hongjun BianShandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatitis B virus (HBV) e antigen (HBeAg) plays a critical role in inducing macrophage activation and subsequent immune tolerance, which facilitates viral immune escape. However, the underlying spatial 3D genomic and epigenetic mechanisms driving this macrophage dysfunction remain largely unknown. Methods: To map the topological and transcriptional regulatory landscape, we integrated RNA-sequencing (RNA-seq), high-throughput chromosome conformation capture (Hi-C), and chromatin immunoprecipitation-sequencing (ChIP-seq) to comprehensively analyze control and HBeAg-stimulated macrophages. Key findings were cross-validated using human HBV-infected datasets. Result: HBeAg robustly activated pro-inflammatory transcriptional programs, prominently featuring the TNF signaling pathway as a central node. Hi-C analysis revealed profound global 3D chromatin reorganization accompanying this phenotypic shift. Specifically, inactive-to-active (B-to-A) compartment switching, coupled with Conclusion: HBeAg orchestrates a highly coordinated hierarchical restructuring of the 3D genome and targeted epigenetic reprogramming to induce macrophage dysfunction. The identified structural variants and core spatial-target genes (such as MET, FLNB, and BLVRB) provide novel mechanistic insights and represent potential therapeutic targets for HBV-related liver diseases.

Indexed as

ChromatinHepatitis BHepatitis B e AntigensHepatitis B virusMacrophagesChromatin Assembly and DisassemblyChromatin Immunoprecipitation SequencingEpigenesis, GeneticHumansMacrophage ActivationChromatinHepatitis B e AntigensHBeAgHi-Clivermacrophagethree-dimensional (3D) chromatin architecture

Identifiers

PMID42534908
PMCPMC13422226

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.